Gabapentin
- Generic Name
- Gabapentin
- Brand Names
- Gralise, Neurontin
- Drug Type
- Small Molecule
- Chemical Formula
- C9H17NO2
- CAS Number
- 60142-96-3
- Unique Ingredient Identifier
- 6CW7F3G59X
- Background
Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that was first approved for use in the United States in 1993. It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures - today it is also widely used to treat neuropathic pain. Gabapentin has some stark advantages ...
- Indication
In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older. In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or...
- Associated Conditions
- Partial-Onset Seizures, Peripheral Neuropathic Pain, Postherpetic Neuralgia
- Associated Therapies
- -
A Phase III Open-Label Extension Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2021-02-03
- Target Recruit Count
- 65
- Registration Number
- NCT00620555
- Locations
- 🇯🇵
Pfizer Investigational Site, Yamagata, Japan
Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy
- Conditions
- Interventions
- First Posted Date
- 2008-02-21
- Last Posted Date
- 2018-09-11
- Lead Sponsor
- Wake Forest University
- Target Recruit Count
- 22
- Registration Number
- NCT00619983
- Locations
- 🇺🇸
Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
A Phase III Open-Label Study Of Gabapentin As Adjunctive Therapy In Japanese Pediatric Patients With Partial Seizures
- First Posted Date
- 2008-01-29
- Last Posted Date
- 2021-02-03
- Target Recruit Count
- 92
- Registration Number
- NCT00603473
- Locations
- 🇯🇵
Pfizer Investigational Site, Yamanashi, Japan
Drug Discrimination in Methadone-Maintained Humans Study 1
- Conditions
- Interventions
- First Posted Date
- 2008-01-15
- Last Posted Date
- 2011-03-11
- Lead Sponsor
- University of Arkansas
- Target Recruit Count
- 40
- Registration Number
- NCT00593463
- Locations
- 🇺🇸
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Preoperative Gabapentin for Acute and Chronic Post-thoracotomy Analgesia
- First Posted Date
- 2008-01-08
- Last Posted Date
- 2016-05-04
- Lead Sponsor
- Michelle Kinney
- Target Recruit Count
- 146
- Registration Number
- NCT00588159
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis
- Conditions
- Interventions
- First Posted Date
- 2008-01-02
- Last Posted Date
- 2021-02-02
- Target Recruit Count
- 8
- Registration Number
- NCT00584779
- Locations
- 🇯🇵
Pfizer Investigational Site, Aira-gun, Aira-cho, Kagoshima-ken, Japan
Gabapentin - A Solution to Uremic Pruritus?
- First Posted Date
- 2007-12-20
- Last Posted Date
- 2010-07-07
- Lead Sponsor
- Hospital Authority, Hong Kong
- Target Recruit Count
- 80
- Registration Number
- NCT00577967
- Locations
- 🇨🇳
Tuen Mun Hospital, Hong Kong, China
The Effectiveness and Safety of Gabapentin for Post-operative Pain After Cesarean Section
- First Posted Date
- 2007-12-14
- Last Posted Date
- 2009-07-30
- Target Recruit Count
- 46
- Registration Number
- NCT00573664
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
Drug Use Investigation Of Gabapentin
- First Posted Date
- 2007-12-04
- Last Posted Date
- 2021-02-03
- Target Recruit Count
- 1273
- Registration Number
- NCT00567268
Effect of Gabapentin on Idiopathic Subjective Tinnitus
- First Posted Date
- 2007-11-09
- Last Posted Date
- 2009-01-06
- Lead Sponsor
- Islamic Azad University of Mashhad
- Target Recruit Count
- 70
- Registration Number
- NCT00555776
- Locations
- 🇮🇷
ENT department of Mashhad Azad medical university, Mashhad, Khorasan razavi, Iran, Islamic Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.